missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Fumarato de 3-etilo, 5-metil 2-[(2-aminoetoxi)metil]-4-(2-clorofenil)-6-metilpiridina-3,5-dicarboxilato, Mikromol™
Description
Fumarato de 3-etilo, 5-metilo y 2-[(2-aminoetoxi)metil]-4-(2-clorofenil)-6-metilpiridina-3,5-dicarboxilato
Specifications
Specifications
| Nombre del producto químico o material | 3-Ethyl 5-Methyl 2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate Fumarate |
| CAS | 2138811-33-1 |
| Nombres de analitos o componentes | 3-Ethyl 5-Methyl 2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate Fumarate |
| Condiciones de envío | Room Temperature |
| Fórmula molecular | C20 H23 Cl N2 O5 . C4 H4 O4 |
| Certificaciones/conformidad | ISO 17025 |
| Sinónimo | Amlodipine Besilate Imp. D (EP), Amlodipine Imp. D (EP), Amlodipine USP Related Compound A, Amlodipine USP RC A, Imp. D (EP) as Fumarate: 3-Ethyl 5-Methyl 2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate Fumarate, 3-Ethyl 5-methyl [2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-3,5-pyridinedicarboxylate] fumarate, Amlodipine Related Compound A as Fumarate, Amlodipine Besilate Impurity D as Fumarate, Amlodipine Impurity D as Fumarate |
| Fórmula InChI | InChI=1S/C47H53ClN3O3.BrH/c1-49(2)43(52)46(38-17-9-5-10-18-38,39-19-11-6-12-20-39)31-35-51(33-29-45(54,30-34-51)37-25-27-42(48)28-26-37)36-32-47(44(53)50(3)4,40-21-13-7-14-22-40)41-23-15-8-16-24-41;/h5-28,54H,29-36H2,1-4H3;1H/q+1;/p-5 |
| SMILES | CCOC(=O)c1c(COCCN)nc(C)c(C(=O)OC)c1c2ccccc2Cl.OC(=O)\C=C\C(=O)O |
| Nombre IUPAC | Ácido (E)-but-2-enedioico; 2-(2-aminoetoximetil)-4-(2-clorofenil)-6-metilpiridina-3,5-dicarboxilato de 3-O-etilo y 5-O-metilo |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?